:max_bytes(133120)/d2j5s05om7evfr.cloudfront.net/pubmed-llm-images/40000534/8ad5e160a118c392c36cdbb9c75e8ed4_wm.png)
Identifying long-term patterns and predictors of concurrent psychotropic medicine use in residential aged care using group-based multi-trajectory modelling: the 'MEDTRAC-Psychotropics' longitudinal cohort study.
Summary: Moving a loved one into a residential aged care facility is a significant life transition, often accompanied by complex health needs. A recent study in Sydney, Australia, tracked nearly 3,000 newly admitted residents over three years to understand how medications affecting the mind—such as antidepressants, antipsychotics, and sedatives—are used. The researchers found that "polypharmacy," or the use of multiple psychotropic drugs at the same time, is strikingly common. One in three residents with dementia and one in five without dementia were found to be on these drug cocktails, often for extended periods. While these medications can be necessary, their long-term combined use raises safety concerns. The study highlights the need for careful, ongoing review of medications to ensure they are helping rather than harming our elderly population.